|
HS Code |
169581 |
| Chemical Name | Suramin Sodium |
| Molecular Formula | C51H33N6Na6O23S6 |
| Molecular Weight | 1429.36 g/mol |
| Cas Number | 150-38-9 |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Storage Temperature | 2-8°C |
| Purity | ≥98% (HPLC) |
| Application | Pharmaceutical intermediate, antiparasitic agent |
| Synonyms | Bayer 205, Germanin |
| Ph Of Solution | Approx. 7.0 (1% solution in water) |
| Brand Names | Antrypol |
| Route Of Administration | Intravenous |
| Mechanism Of Action | Inhibits enzymes involved in energy metabolism |
As an accredited Suramin Sodium factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Suramin Sodium is supplied in a 1g amber glass vial, sealed with a rubber stopper and aluminum cap, with clear labeling. |
| Shipping | Suramin Sodium is shipped in tightly sealed, chemical-resistant containers to protect from moisture and light. Packaging complies with international regulations for hazardous materials. Temperature is maintained at ambient conditions unless specified otherwise. Each shipment includes safety data sheets and proper labeling to ensure safe handling and storage during transit. |
| Storage | Suramin Sodium should be stored in a tightly closed container, protected from light and moisture, at a temperature between 2°C and 8°C (refrigerated conditions). It must be kept away from incompatible substances and stored in a secure, well-ventilated area to prevent contamination or degradation. Proper labeling and safety precautions should always be observed during storage and handling. |
Applications of Suramin Sodium in Industrial ManufacturingSuramin Sodium serves as a specialized synthetic polyanionic compound with recognized use in critical industrial and pharmaceutical processes. As a dedicated upstream producer, we support global manufacturers with consistent Suramin Sodium supply, conforming to stringent international standards for precise application in key downstream sectors. 1. Active Pharmaceutical Ingredient (API) Production: Antiparasitic and Antiviral DrugsMajor pharmaceutical manufacturers utilize Suramin Sodium as a core intermediate in the synthesis of antiparasitic and certain antiviral APIs, particularly for drugs targeting trypanosomiasis. Precise formulation begins at the API stage, incorporating Suramin Sodium during early synthesis through controlled reaction vessels, followed by purification and crystallization. The compound’s unique polyanionic structure demands close process monitoring and batch documentation to satisfy strict release criteria. API producers adapt usage levels in accordance with target final dosages, process yields, and route of synthesis, ensuring full regulatory alignment from raw material input to finished API lots for global distribution. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Veterinary Pharma Manufacturing: Trypanocidal FormulationsVeterinary pharmaceutical formulation plants incorporate Suramin Sodium as a principal component for livestock and animal care medications against trypanosome infections. The raw compound merges with solvent carriers and stabilizing excipients during granulation or blending phases, followed by strict sterility and shelf-life testing. Downstream processes must maintain component homogeneity and conform to pharmacopeial standards for non-human medicinal use, reporting full traceability from raw input to batch packing for regulatory submission. Dosage calibration reflects the intended animal species, administration route, and therapeutic index requirements, ensuring regulatory and safety targets are met for each regional market. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Diagnostic Reagent Production: Enzyme Inhibition and Research KitsResearch and diagnostics manufacturers employ Suramin Sodium as a selective enzyme inhibitor in quantitative diagnostic kits and biochemical assays, especially for molecular analysis and in vitro research. The compound supplies controlled enzyme inhibition in high-throughput automated analyzers, providing standardization for assay performance. Process teams introduce Suramin Sodium at dosing steps relying on precise analytical weighing and solubilization to achieve requisite inhibitory concentration, often in buffered solutions tailored for each assay format. Formulators adjust ratios based on target enzyme, plate format, and target sensitivity; finished kits undergo full batch validation for laboratory or research institution delivery. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Bioprocessing & Biotechnology: Cell Culture and Screening ApplicationsBiotechnology production facilities integrate Suramin Sodium as an adjuvant or cell response modulator in advanced screening platforms and selective cell culture applications, including cancer and viral infection research. Downstream teams dissolve Suramin Sodium into sterile culture mediums at threshold concentrations to probe cell response pathways or screen candidate drugs, closely linking raw input calibration to biological endpoint testing. Its polyanionic properties require protection from ionic contaminants and precise batch records, supported by continuous monitoring under GMP bioprocess conditions for experimental reproducibility and regulatory documentation. Adjustments in concentration depend on target cell models, experimental timepoints, and downstream analysis requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Suramin Sodium prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Suramin Sodium holds a unique spot in our product line, not simply as a compound with an impressive chemical pedigree but as a substance that has stood the test of time in research and industrial medicine. Every batch that comes off our production line reflects our years of process improvement, investment in engineering solutions, and dedication to meeting the real needs of global scientists and formulation chemists.
Our Suramin Sodium, produced under controlled manufacturing protocols, carries the model number SRN-2452. The standard specification falls in the purity range above 99% based on HPLC analysis—a figure that synthetic labs and researchers have pushed us to maintain for reliable downstream application. Particle size and solubility profiles align with laboratory needs. Each lot passes our internal endotoxin test and records show stable results over years of continuous manufacture.
Requests for Suramin Sodium come steadily. Most originate from research labs probing antiviral mechanisms, anti-parasitic activity, or even testing as a tool for biochemical assays. We hear from pharmaceutical developers targeting enzyme inhibition, as well as biologists studying nucleotide-binding proteins. Whether the order is for milligrams or multi-kilogram batches, much of the drive for Suramin relates to its function as an inhibitor at the molecular level. This requires absolute consistency and freedom from unwanted trace contaminants, especially phosphate and heavy metals, which could confound sensitive cell or tissue work. Our team tailors the entire synthesis chain, from raw material sourcing through final filtration, to minimize batch-to-batch variation.
The sodium salt form of Suramin demonstrates high solubility in water—even at low temperatures, we see complete dissolution at concentrations appropriate for bioassay use. We have been challenged more than once to reduce insoluble traces and cut down on micro-particulate residues. Initial approaches included improving our filtration membranes and re-configuring some crystallization steps. After two years of pilot runs and end-user feedback, we achieved a marked reduction in insoluble residue, with most lots now yielding clear, nearly colorless solutions free from visible debris.
Specifications on paper tell only half the story. Purchasers ask whether any generic Suramin source suffices. Years in manufacturing have demonstrated the hard truth: even minor shifts in process control yield large impacts in end use. One year, we observed issues with dissolution times. Incoming raw material analysis flagged a new contaminant profile—trace pentasodium variants—that altered solubility. Only by increasing our raw material rejection threshold and tuning in-process washing routines did we regain complete dissolution performance.
There are differences between Suramin Sodium from ourselves and material from brokers or low-volume importers. Some suppliers vacuum dry at higher heat, which leaves subtle degradation products—these rarely appear in a basic assay but create hurdles for high-sensitivity research. We run semi-batch synthesis with gradual temperature ramping, which slows throughput, but results in purer end product. Our analytical work regularly identifies residual chlorides in certain third-party samples, especially from small-scale syntheses performed outside a GMP environment. Small changes in scaling, filtration, or drying lead to real differences at the bench.
The actual powder, when done right, carries a distinctive light blue color—non-fading during storage, even under fluctuating temperature and humidity conditions. Product arriving pale or off-color signals poor process control or contamination, confirmed by spectral and HPLC checks. We invest in robust packaging to preserve the chemical’s state during overseas transit, using reinforced drums and inert barriers to prevent absorption of atmospheric moisture or ambient volatiles.
Trust gets built through problem-solving, not just order fulfillment. Over the years, multiple international research groups have sent us samples of Suramin Sodium for troubleshooting. Common complaints detail inconsistencies in compound solubility, trace toxicity in cell cultures, or interference with fluorometric assays. Sometimes, the problem traces back to micro-level contaminants introduced during crystallization or drying. We continually refine our processes after reviewing independent laboratory results. Recently, one team found significant interference in protein-ligand assays from Suramin sourced outside our company; in side-by-side runs, our batches produced clean, reproducible data. This isn’t anecdote—our analytical department archives these comparative studies, helping us verify and reinforce the value of our quality control investments.
Certain partners need documentation for every stage of the chain: starting material certification, in-process analysis, residual solvent profiling, endotoxin and bioburden testing results, residual heavy metal quantitation, and impurity profiling by high-resolution LC-MS. We maintain detailed records and supply full reports on demand. Many buyers reach out precisely because they have experienced unexplained failures with off-specification Suramin and seek to eliminate variables in their workflows.
In practice, Suramin Sodium gets used under a tight set of protocols. Dissolution in buffered systems sometimes raises issues with precipitation, particularly at high concentration or under rapid temperature shifts. Years of feedback led us to recommend adding it slowly and gently agitating; rapid dumping or harsh stirring at cold temperatures leads to microcrystal formation and delayed dissolution. Stability data from our own studies indicate the compound remains functional and stable in well-sealed containers away from sunlight for at least 24 months. Repeated opening under humid air gradually introduces surface clumping, so we ship in tightly sealed, desiccated containers and recommend dividing supplies into working aliquots for ongoing projects.
From a worker’s perspective in both pilot plant and packaging, correct PPE (personal protective equipment) is essential. Suramin Sodium, taken as a pure powder, should not contact bare skin or mucous membranes. Laboratory experience cautions against generation of fine dust, which may irritate skin or eyes after accidental exposure. Internally, our own safety reviews have not flagged special hazards during normal processing, but we enforce strict protocols to prevent accidental inhalation or ingestion. Recordkeeping helps track any occupational exposures and ensures we handle all regulatory checks efficiently.
Direct suppliers hold the advantage of process transparency. Buyers who approach us speak directly with responsible staff. No middlemen, no rerouted paperwork, direct technical discussion. This enables us to troubleshoot in real-time and adapt batch characteristics as lab needs change. In one example, a long-term customer required minimal traces of phosphates to avoid artifacts in a fluorescence assay. We ran a modified purification step, monitored final HPLC-CAD results, and delivered a batch meeting their needs—not something feasible through distributors tied to inflexible upstream supply chains.
For projects that extend over months or years, researchers demand batch-to-batch consistency as a foundation for experimental reproducibility. Our engineering department tracks every parameter from water quality and pH to room humidity and vacuum level throughout the cycle. Electronic records link samples from production, QC testing, storage, and shipping, making it straightforward to check any given lot’s history. Each kilogram of Suramin Sodium from our site has a data trail from raw material receipt through packing.
Suramin Sodium doesn’t stand alone in the chemical toolkit. Researchers frequently compare it with analogues such as pentamidine, diminazene, or new nucleic acid-interacting compounds. Experience shows that while these molecules share certain binding properties or mechanistic similarities, each responds differently under assay conditions, especially in presence of metal ions, pH shifts, or competing substrates. Suramin Sodium, as produced here, brings broad-spectrum inhibitory action, but also exhibits a unique profile of selectivity. This turns crucial for work on specific enzymes or signal transduction pathways.
Occasionally, labs run into problems when switching sources. Slightly altered impurity content or alternative salt forms result in shifts in solubility or assay background. Genuine Suramin Sodium from our plant, with its consistent sodium counter-ion content, brings less background interference than some ammonium or lithium salt variants. Repeat orders often stem from researchers identifying background jumps traced to out-of-spec alternatives. We advise checking full impurity reports—not every source will voluntarily provide them, and not every deviation can be seen without advanced analytical tools.
Markets shift, logistics contest smooth operations, yet the need for Suramin Sodium runs strong and steady. The COVID-19 pandemic spiked demand as international studies explored Suramin’s antiviral potential, pressuring the supply chain and stretching lead times. We took steps to expand reactor capacity and streamline purification, ensuring fulfillment without compromise in purity. The shift underscored the value of transparent communication—updates on batch schedules and lead times helped partners plan projects rather than leave orders in limbo.
Economic disruptions, variable customs clearance, or shipping delays threaten delivery, but building supply flexibility minimizes risk. We keep buffer stocks of raw materials and pre-qualified intermediates to cushion against shipping shocks. Systems for rapid customs documentation and packaging design that absorbs impact from bumpy transport round out the reliability we bring as a manufacturer.
Process improvement never ends. Annual reviews of process flow charts, maintenance logs, and feedback from end-users point us in the right direction. Technicians administer in-line monitoring to spot points of deviation, shutting down a line at the first sign of out-of-specification product. A few years ago, we overhauled initial filtration stages after reviewing a surge of user reports about sub-visible particles. Updated equipment and revised filter sizing produced an immediate decline in complaints and measurable improvements in clarity and solubility.
On the analytical side, we invested in new equipment for trace heavy metal detection and low-level impurity profiling. Contract testing with third-party labs keeps our reporting honest and validation strong. Regulators or institutional buyers auditing our site have walked through every step—tours welcome their questions, driving improvements in areas from chemical handling to batch record retention.
Custom synthesis or batch modification is part of everyday work. Some customers push for alternate granulometry, lower bioburden, or exceptional physical stability. Not every request aligns with chemical science, yet every inquiry pushes our process understanding. We experiment, review, and sometimes initiate scale-up if results prove repeatable and worthwhile. Internal review balances production costs and demand, and we inform repeat buyers of innovations as they come online.
In addition, collaborative R&D between in-house teams and clients sometimes leads to better process chemistry or improved analytical assays. We support pilot studies by providing full datasets and sample quantities tailored for validation. This feedback loop, direct and immediate, shapes our ability to innovate in both product quality and consistency. We recognize the needs of those at the front lines of scientific discovery, and our experience teaches that reliability builds reputation over any marketing claim.
Our plant sits within industrial zoning, surrounded by companies working just as hard on their own chemistries. Regulations focus not just on output but on the way production integrates with local community needs. We maintain strict emissions controls, solvent recovery, and local regulatory reporting. Waste streams are monitored by our in-house team, who ensure discharge limits stay well within regulatory boundaries. Every year, our environmental engineers audit procedures, adapting to new standards as they emerge. Industry peers often call for advice on process optimization, showing that know-how in manufacturing Suramin Sodium extends into broader chemical responsibility.
Workers here participate in ongoing safety and chemical stewardship training, fostering a culture where process safety and environmental concerns come neck-and-neck with output goals. We invite regulatory inspectors regularly—not only for compliance but also to challenge our protocols. From procurement of certified raw materials to final product shipment, chain of custody reporting assures the buyer that production follows ethical as well as scientific principles.
No production cycle passes without issues. Repeated challenges include solubility fluctuations, color shift in storage, and shipment delays. For solubility, unexpected precipitation in some batches often comes from subtle hydration differences in the sodium salt or inadvertent introduction of magnesium or calcium traces. We now test incoming water and track system pH to a higher resolution, catching deviations earlier. Following a batch that showed minor color fade after months in storage, we traced the root cause to insufficient light protection. Increasing packaging opacity, using inner foil liners, and improving drum seals solved the issue, verified by year-long stability tests.
Shipping delays call for communication at every step—real-time tracking and buffer stock management keep laboratories supplied, even during global logistics crunch periods. Production staff share the same urgency as purchasing officers: deliveries enable discovery, drive medical research, and keep manufacturing schedules on track. We prioritize both speed and safe handling, never cutting corners on labeling, packaging, or regulatory compliance.
Ultimate confidence in Suramin Sodium stems from disciplined process and clear, validated analytics. Every batch leaving our site comes with an assay report and full certificate of analysis. Experienced buyers spot the difference by running side-by-side comparison tests or reviewing long-term project results. Laboratories pursuing regulatory filings, clinical studies, or industrial applications find peace of mind not in chemical jargon but in the data linking raw material to final product, every step documented, every lot traceable.
Our efforts focus on strengthening that backbone of support for scientists, process engineers, and frontline workers in both established and emerging research fields. Decades in chemical manufacturing have taught us that listening, adapting, and learning build better products and stronger relationships. Suramin Sodium, as we make it, embodies this approach—backed by results delivered not only by us, but by the worldwide community who rely on us.